CAMRF
Price:
$54.95
Market Cap:
$30.86B
Camurus AB (publ) is a pharmaceutical enterprise dedicated to the development and global commercialization of therapeutic solutions for severe and enduring medical conditions. Its operations span across Europe, Australia, the United States, Japan, and other international markets. Currently available products include Buvidal, a buprenorphine injection designed to manage opioid dependence; episil oral liquid, classified as a medical device for alleviating inflammatory and painful conditions within the oral cavity; and Brixadi, another treatment option for opioid use disorder. Beyond its established offerings, Camurus maintains a robust research and development pipeline featuring several promis...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-12-11
Stock Exchange
OTC
Ticker
CAMRF
According to Camurus AB (publ)’s latest financial reports and current stock price. The company's current ROE is 16.39%. This represents a change of 294.10% compared to the average of 4.16% of the last 4 quarters.
The mean historical ROE of Camurus AB (publ) over the last ten years is -16.83%. The current 16.39% ROE has changed -197.42% with respect to the historical average. Over the past ten years (40 quarters), CAMRF's ROE was at its highest in in the June 2023 quarter at 21.81%. The ROE was at its lowest in in the December 2018 quarter at -34.54%.
Average
-16.83%
Median
-12.50%
Minimum
-93.01%
Maximum
28.90%
Discovering the peaks and valleys of Camurus AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 417.41%
Maximum Annual ROE = 28.90%
Minimum Annual Increase = -152.42%
Minimum Annual ROE = -93.01%
| Year | ROE | Change |
|---|---|---|
| 2025 | 17.37% | 33.36% |
| 2024 | 13.02% | -54.94% |
| 2023 | 28.90% | 417.41% |
| 2022 | 5.59% | -152.42% |
| 2021 | -10.65% | -46.02% |
| 2020 | -19.74% | -56.99% |
| 2019 | -45.89% | -50.66% |
| 2018 | -93.01% | 87.89% |
| 2017 | -49.50% | 244.95% |
| 2016 | -14.35% | -42.39% |
The current ROE of Camurus AB (publ) (CAMRF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
19.76%
5-year avg
10.84%
10-year avg
-16.83%
Camurus AB (publ)’s ROE is less than Laboratorios Farmaceuticos Rovi, S.A. (20.89%), less than Santen Pharmaceutical Co., Ltd. (13.15%), greater than Genscript Biotech Corporation (-12.72%), less than ALK-Abelló A/S (20.45%), less than Ambu A/S (7.92%), less than InnoCare Pharma Limited (10.12%), greater than Shanghai Junshi Biosciences Co., Ltd. (-10.78%), greater than Telix Pharmaceuticals Limited (-1.72%), less than Livzon Pharmaceutical Group Inc. (13.95%), less than Galapagos N.V. (16.88%),
| Company | ROE | Market cap |
|---|---|---|
| 20.89% | $4.63B | |
| 13.15% | $3.54B | |
| -12.72% | $3.50B | |
| 20.45% | $8.18B | |
| 7.92% | $2.56B | |
| 10.12% | $2.32B | |
| -10.78% | $4.84B | |
| -1.72% | $3.26B | |
| 13.95% | $6.06B | |
| 16.88% | $1.85B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Camurus AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Camurus AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Camurus AB (publ)'s ROE?
How is the ROE calculated for Camurus AB (publ) (CAMRF)?
What is the highest ROE for Camurus AB (publ) (CAMRF)?
What is the 3-year average ROE for Camurus AB (publ) (CAMRF)?
What is the 5-year average ROE for Camurus AB (publ) (CAMRF)?
How does the current ROE for Camurus AB (publ) (CAMRF) compare to its historical average?